Did Josh Gottheimer buy Biomarin Pharmaceutical stock?

Common questions

Did Josh Gottheimer buy Biomarin Pharmaceutical stock?

Yes. Josh Gottheimer disclosed 3 purchases and 1 sale of Biomarin Pharmaceutical (BMRN) stock between Dec 11, 2019 and Oct 18, 2021, in STOCK Act reports. Added together, the disclosed purchases come to $3K-$45K and the disclosed sales to $1K-$15K.

How big were Josh Gottheimer's Biomarin Pharmaceutical trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $3K-$45K and the disclosed sales to $1K-$15K.

Did Josh Gottheimer make these Biomarin Pharmaceutical trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Josh Gottheimer still own Biomarin Pharmaceutical stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Josh Gottheimer report these trades?

The latest filing is dated Nov 15, 2021. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.